Dermaseptin
FDA Label NDC 61924-210

9 label sections · Submitted to the FDA by Dermarite Industries, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Dermarite Industries, Llc for the product Dermaseptin (NDC 61924-210). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose:, uses:, warnings, warnings:, directions, other information:, inactive ingredients:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

  • Zinc Oxide 19%
  • Calamine 2%

Purpose:

  • Zinc Oxide: Skin protectant
  • Calamine : Skin protectant

Uses:

Dries the oozing and weeping of poison:

  • Ivy
  • Oak
  • Sumac
  • Or othe skin irritations

Warnings

  • For external use only.
  • Avoid contact with eyes. In case of contact, flush thoroughly with water.
  • Stop use and ask a doctor if condition worsens
  • Symptoms last more than 7 days or clear up and occur again within a few days.

Warnings:

  • Keep out of reach of children. In case accidental ingestion contact a physician or Poison Control Center right away.

Directions


Applied as needed.

Other Information:

Store at room temperature (59°-86°F).

You may report a serious adverse event to DermaRite Industires, PO Box 7209, North Bergen, NJ 07047.

Inactive Ingredients:

Petrolatum, Lanolin, Glycerin, Menthol, Sodium Bicarbonate, methylparaben, Propylparaben

* Please review the disclaimer below.